^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

TBI-1501

i
Other names: TBI-1501, CD19-CAR gene therapy, CD19-CAR T cell therapy, CD19 chimeric antigen receptor T cell therapy , TBI 1501, TBI1501
Associations
Trials
Company:
Jichi Medical University, Takara
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials